You are here

  • Home
  • Archive
  • Volume 2, Issue Suppl 3
  • Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)

Article metrics

Article menu

Download PDFPDF

Poster Presentation
Patterns of response in patients with advanced melanoma treated with Pembrolizumab (MK-3475) and evaluation of immune-related response criteria (irRC)

 

Online download statistics by month:

Online download statistics by month: December 2019 to June 2025

AbstractFullPdf
Dec 2019010
Jan 2020031
Feb 2020054
Mar 2020011
Apr 2020001
May 2020032
Jun 2020093
Jul 2020031
Sep 2020060
Oct 2020033
Nov 2020020
Dec 2020033
Jan 2021081
Feb 2021021
Mar 2021020
Apr 2021042
Jun 2021010
Jul 2021071
Aug 2021033
Sep 2021052
Oct 20210516
Nov 20210718
Dec 2021071
Jan 2022074
Feb 2022082
Mar 2022081
Apr 2022061
May 2022058
Jun 2022043
Jul 2022051
Aug 2022043
Sep 2022064
Oct 2022054
Nov 2022083
Dec 2022090
Jan 2023081
Feb 2023042
Mar 20230101
Apr 2023041
May 2023083
Jun 2023050
Jul 2023045
Aug 2023032
Sep 2023011
Oct 2023023
Nov 2023041
Dec 2023092
Jan 2024041
Feb 20240143
Mar 20240587
Apr 202401214
May 2024096
Jun 2024081
Jul 20240103
Aug 2024042
Sep 20240104
Oct 20240104
Nov 2024075
Dec 2024071
Jan 202501113
Feb 2025052
Mar 202501912
Apr 20250181
May 20250123
Jun 20250118
Total0403290